Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034695918> ?p ?o ?g. }
- W2034695918 endingPage "2021" @default.
- W2034695918 startingPage "2010" @default.
- W2034695918 abstract "Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes.BackgroundDecay-accelerating factor (DAF) has inhibitory activity toward complement C3 and C5 convertases. DAF is present in human glomeruli and on cultured human glomerular visceral epithelial cells (GEC). We studied the distribution and function of rat DAF.MethodsFunction-neutralizing antibodies (Abs) were raised against DAF. The distribution of DAF in vivo was determined by immunoelectron microscopy. Functional studies were performed in cultured GEC and following IV injection of anti-DAF Abs into rats.ResultsDAF was present exclusively on the apical surfaces of GEC, and was not present on the basal surfaces of GEC, nor other glomerular or kidney cells. DAF was functionally active on cultured GEC, and served to limit complement activation in concert with CD59, an inhibitor of C5b-9 formation. Upon injection into normal rats, anti-DAF F(ab′)2 Abs bound to GEC in vivo, yet there was no evidence for complement activation and animals did not develop abnormal albuminuria. Anti-megalin complement-activating IgG Abs were “planted” on GEC, which activated complement as evidenced by the presence of C3d on GEC. Attempts to inhibit DAF function with anti-DAF Abs did not affect the quantity of complement activation by these anti-megalin Abs, nor did it lead to development of abnormal albuminuria. In contrast, in the puromycin aminonucleoside model of GEC injury and proteinuria, anti-DAF Abs slowed the recovery from renal failure that occurs in this model.ConclusionIn cultured rat GEC, DAF is an effective complement regulator. In vivo, DAF is present on GEC apical surfaces. Yet, it appears that DAF is not essential to prevent complement activation from occurring under normal circumstances and in those cases in which complement-activating Abs are present on the basal surfaces of GEC in vivo. However, in proteinuric conditions, DAF appears to be protective to GEC. Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes. Decay-accelerating factor (DAF) has inhibitory activity toward complement C3 and C5 convertases. DAF is present in human glomeruli and on cultured human glomerular visceral epithelial cells (GEC). We studied the distribution and function of rat DAF. Function-neutralizing antibodies (Abs) were raised against DAF. The distribution of DAF in vivo was determined by immunoelectron microscopy. Functional studies were performed in cultured GEC and following IV injection of anti-DAF Abs into rats. DAF was present exclusively on the apical surfaces of GEC, and was not present on the basal surfaces of GEC, nor other glomerular or kidney cells. DAF was functionally active on cultured GEC, and served to limit complement activation in concert with CD59, an inhibitor of C5b-9 formation. Upon injection into normal rats, anti-DAF F(ab′)2 Abs bound to GEC in vivo, yet there was no evidence for complement activation and animals did not develop abnormal albuminuria. Anti-megalin complement-activating IgG Abs were “planted” on GEC, which activated complement as evidenced by the presence of C3d on GEC. Attempts to inhibit DAF function with anti-DAF Abs did not affect the quantity of complement activation by these anti-megalin Abs, nor did it lead to development of abnormal albuminuria. In contrast, in the puromycin aminonucleoside model of GEC injury and proteinuria, anti-DAF Abs slowed the recovery from renal failure that occurs in this model. In cultured rat GEC, DAF is an effective complement regulator. In vivo, DAF is present on GEC apical surfaces. Yet, it appears that DAF is not essential to prevent complement activation from occurring under normal circumstances and in those cases in which complement-activating Abs are present on the basal surfaces of GEC in vivo. However, in proteinuric conditions, DAF appears to be protective to GEC." @default.
- W2034695918 created "2016-06-24" @default.
- W2034695918 creator A5007061396 @default.
- W2034695918 creator A5024189919 @default.
- W2034695918 creator A5037240171 @default.
- W2034695918 creator A5043487482 @default.
- W2034695918 creator A5062176433 @default.
- W2034695918 creator A5071999370 @default.
- W2034695918 creator A5087485954 @default.
- W2034695918 creator A5090001718 @default.
- W2034695918 creator A5090102833 @default.
- W2034695918 creator A5090990910 @default.
- W2034695918 creator A5091335417 @default.
- W2034695918 date "2002-12-01" @default.
- W2034695918 modified "2023-10-15" @default.
- W2034695918 title "Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes" @default.
- W2034695918 cites W1500833770 @default.
- W2034695918 cites W1534220125 @default.
- W2034695918 cites W1554698729 @default.
- W2034695918 cites W1639198537 @default.
- W2034695918 cites W1714774488 @default.
- W2034695918 cites W1922947289 @default.
- W2034695918 cites W1974517821 @default.
- W2034695918 cites W1977591188 @default.
- W2034695918 cites W1979798935 @default.
- W2034695918 cites W1987810985 @default.
- W2034695918 cites W1999148829 @default.
- W2034695918 cites W2000826743 @default.
- W2034695918 cites W2003929885 @default.
- W2034695918 cites W2007642085 @default.
- W2034695918 cites W2013203608 @default.
- W2034695918 cites W2016317661 @default.
- W2034695918 cites W2023668677 @default.
- W2034695918 cites W2034106313 @default.
- W2034695918 cites W2037805609 @default.
- W2034695918 cites W2038384507 @default.
- W2034695918 cites W2038782622 @default.
- W2034695918 cites W2045558862 @default.
- W2034695918 cites W2048538843 @default.
- W2034695918 cites W2049444324 @default.
- W2034695918 cites W2052103695 @default.
- W2034695918 cites W2070729260 @default.
- W2034695918 cites W2070947895 @default.
- W2034695918 cites W2073917494 @default.
- W2034695918 cites W2079820146 @default.
- W2034695918 cites W2081210113 @default.
- W2034695918 cites W2083031926 @default.
- W2034695918 cites W2088737496 @default.
- W2034695918 cites W2094049563 @default.
- W2034695918 cites W2115983312 @default.
- W2034695918 cites W2120467386 @default.
- W2034695918 cites W2124410251 @default.
- W2034695918 cites W2127425255 @default.
- W2034695918 cites W2131325111 @default.
- W2034695918 cites W2135950741 @default.
- W2034695918 cites W2142480343 @default.
- W2034695918 cites W2144932484 @default.
- W2034695918 cites W2155571650 @default.
- W2034695918 cites W2157619027 @default.
- W2034695918 cites W2165697745 @default.
- W2034695918 cites W2174272589 @default.
- W2034695918 cites W2323555293 @default.
- W2034695918 cites W315197452 @default.
- W2034695918 doi "https://doi.org/10.1046/j.1523-1755.2002.t01-1-00652.x" @default.
- W2034695918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12427125" @default.
- W2034695918 hasPublicationYear "2002" @default.
- W2034695918 type Work @default.
- W2034695918 sameAs 2034695918 @default.
- W2034695918 citedByCount "26" @default.
- W2034695918 countsByYear W20346959182012 @default.
- W2034695918 countsByYear W20346959182013 @default.
- W2034695918 countsByYear W20346959182016 @default.
- W2034695918 countsByYear W20346959182017 @default.
- W2034695918 countsByYear W20346959182019 @default.
- W2034695918 countsByYear W20346959182021 @default.
- W2034695918 countsByYear W20346959182022 @default.
- W2034695918 countsByYear W20346959182023 @default.
- W2034695918 crossrefType "journal-article" @default.
- W2034695918 hasAuthorship W2034695918A5007061396 @default.
- W2034695918 hasAuthorship W2034695918A5024189919 @default.
- W2034695918 hasAuthorship W2034695918A5037240171 @default.
- W2034695918 hasAuthorship W2034695918A5043487482 @default.
- W2034695918 hasAuthorship W2034695918A5062176433 @default.
- W2034695918 hasAuthorship W2034695918A5071999370 @default.
- W2034695918 hasAuthorship W2034695918A5087485954 @default.
- W2034695918 hasAuthorship W2034695918A5090001718 @default.
- W2034695918 hasAuthorship W2034695918A5090102833 @default.
- W2034695918 hasAuthorship W2034695918A5090990910 @default.
- W2034695918 hasAuthorship W2034695918A5091335417 @default.
- W2034695918 hasBestOaLocation W20346959181 @default.
- W2034695918 hasConcept C111684460 @default.
- W2034695918 hasConcept C126322002 @default.
- W2034695918 hasConcept C134018914 @default.
- W2034695918 hasConcept C150903083 @default.
- W2034695918 hasConcept C153911025 @default.
- W2034695918 hasConcept C159641895 @default.
- W2034695918 hasConcept C159654299 @default.
- W2034695918 hasConcept C185592680 @default.